European Journal of Molecular & Clinical Medicine

Abstract

In schizophrenia-spectrum illnesses, antipsychotic medication is beneficial for symptomatic therapy. Compared to dose reduction or discontinuation, maintenance of antipsychotic treatment is related to lower recurrence rates and symptom severity after symptom remission. In this research, we will explain how antipsychotic medications can have scalable and non-violent methods for synthesizing major antipsychotic drug compounds such as olanzapine, aripiprazole, quetiapine, and ziprasidone, which have oxidant & antioxidant properties but do not go any further. A single mode of action for many prescribed antipsychotics will be demonstrated for the first time to have no effect on lipid peroxidation.